🧬

Understanding DNA and Down Syndrome

Jan 8, 2025

Lecture on DNA and Down Syndrome

Overview of DNA and Chromosomes

  • DNA is the blueprint for making a human, packaged into chromosomes.
  • Humans have 46 chromosomes, organized into 23 pairs (one from each parent).
  • Reproduction involves both parents contributing 23 chromosomes each.

Down Syndrome

Chromosomal Causes

  • Occurs when one parent contributes an extra chromosome, resulting in 47 chromosomes.
  • Specifically, Down syndrome involves an extra copy of chromosome 21, known as Trisomy 21.

Meiosis and Nondisjunction

  • Meiosis produces sex cells (sperm and egg) each with 23 chromosomes.
  • Nondisjunction:
    • Accounts for 95% of Down syndrome cases.
    • Chromosomes fail to separate properly during meiosis, leading to an extra chromosome in some cells.
    • Can occur during the first or second division stage of meiosis.

Robertsonian Translocation

  • Accounts for 4% of Down syndrome cases.
  • Involves the translocation of chromosome 21 to chromosome 14 or another chromosome.
  • Results in hybrid chromosomes, which can lead to Trisomy 21 or other chromosomal imbalances.

Mosaic Down Syndrome

  • A mix of cells with 46 and 47 chromosomes.
  • Occurs due to nondisjunction during mitosis after conception.
  • Results in varying percentages of affected cells based on when nondisjunction occurs.

Effects of Down Syndrome

  • Affects nearly every organ system due to overexpression of genes on the extra chromosome 21.
  • Common issues:
    • Heart defects (septal defects)
    • Duodenal atresia
    • Increased risk of leukemia
    • Cognitive impairments and increased risk of Alzheimer's
    • Physical characteristics (e.g., flat facial profile, epicanthal folds)

Risk Factors

  • Major risk factor: maternal age.
    • Incidence increases with maternal age, from 1 in 1500 (<20 years) to 1 in 25 (>45 years).

Prenatal Screening and Diagnosis

  • Screening tests include measurements of:
    • Alpha-fetoprotein (AFP)
    • Unconjugated estriol (UE3)
    • Human chorionic gonadotropin (HCG)
    • Inhibin A
  • Ultrasound can assess nuchal translucency.
  • Not definitive, but indicates the risk level.

Quality of Life and Support

  • Improved medical care has enhanced the longevity and quality of life for those with Down syndrome.
  • Many individuals lead full, thriving lives.

Supporting Research and Awareness

  • Support can be provided through donations, subscriptions, and spreading information.